Literature DB >> 3438150

Influence of quinolones on throat- and faecal flora of healthy volunteers.

H G de Vries-Hospers1, G W Welling, D van der Waaij.   

Abstract

Oral and faecal flora were monitored in ten healthy volunteers who received three different oral dosages of either norfloxacin or ciprofloxacin during five consecutive days. Oral flora was not influenced by either quinolone. At the end of the five day-treatment period aerobic Gram-negative bacilli could no longer be cultured from the faecal samples of any of the volunteers. Enterococci were suppressed in some volunteers or remained present in concentrations as high as before treatment. All ciprofloxacin-treated volunteers became colonized with yeasts in their faecal samples, even during treatment with the lowest dose. As measured by total microscopic bacterial clump counts and the appearance of beta-aspartylglycine in faecal samples neither of the two quinolones appeared to decrease the colonization resistance of the digestive tract.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3438150     DOI: 10.1007/BF02075258

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  16 in total

1.  The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.

Authors:  A King; K Shannon; I Phillips
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

2.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

3.  Colonization resistance of the digestive tract: clinical consequences and implications.

Authors:  D van der Waaij
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

4.  Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1971-09

5.  Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Authors:  A L Barry; R N Jones; C Thornsberry; L W Ayers; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

6.  In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Authors:  G M Eliopoulos; A Gardella; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

7.  Comparison of methods for the determination of beta-aspartylglycine in fecal supernatants of leukemic patients treated with antimicrobial agents.

Authors:  G W Welling
Journal:  J Chromatogr       Date:  1982-10-08

8.  In vitro activity of ciprofloxacin (Bay o 9867).

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.

Authors:  H L Muytjens; J van der Ros-van de Repe; G van Veldhuizen
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

10.  Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.

Authors:  M Rozenberg-Arska; A W Dekker; J Verhoef
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

View more
  5 in total

1.  Influence of pefloxacin on microbial colonization resistance in healthy volunteers.

Authors:  E J Vollaard; H A Clasener; A J Janssen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

2.  Low-dose ciprofloxacin for selective decontamination of the digestive tract in human volunteers.

Authors:  G J Meijer-Severs; E van Santen; H G de Vries-Hospers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

Review 3.  Impact of the fluoroquinolones on gastrointestinal flora.

Authors:  V Korten; B E Murray
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 4.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 5.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.